Long-acting injectables (LAI): microsphere design, development and scale-up
Ashland and Oakwood Laboratories will present together, respectively discussing the chemistry of bioresorbable polymers applied to various parenteral formulations and a microsphere technology platform that offers reproducible, scalable, and consistent critical quality attributes under cGMP for multiple therapeutic indications.
Ashland will introduce NEW Viatel™ Ultrapure polymer and detail the advantages of ultra-low (≤ 0.5%) residual monomer specifications. Ashland will show how understanding the chemistry and versatility of Viatel™ polymers helps solve challenges in controlled drug release formulations and medical devices. Oakwood Laboratories will present two small molecule active pharmaceutical ingredient (API) microsphere case studies.
Date: Wednesday, September 6, 2023
Time: 10:00am EDT
Sean McMahon, PhD, global business manager, injectables, Life Sciences, Ashland
Rachel Galaska, formulation engineer, R&D, Oakwood Laboratories
REGISTER HERE to understand how:
• Viatel™ polymer chemistry and process parameter controls can help achieve tunable release profiles of long-acting drug formulations
• development and scale up challenges can be approached and overcome using Chroniject™ technology
• strategies in microsphere technology can be coupled with appropriate bioresorbable polymers to deliver various molecules with tunable release profiles
*Webinar is presented on the Xtalks platform; you will be re-directed to the Xtalks website to register